Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. Despite new rules limiting their manufacture, ...

Glucagon-like peptide-1 receptor agonists (GLP-1s) are a class of medication that includes Ozempic®, Wegovy®, and Saxenda®. Some GLP-1s are diabetes drugs, but you can also take a GLP-1 for weight ...

People who order low-cost versions of the wildly popular weight-loss drugs Wegovy and Zepbound from so-called compounding pharmacies might soon see disruptions in their medication. The U.S. Food and ...

As the demand for GLP-1 medication soars, so does the demand for more affordable formulas. In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, ...

Relations among brand-name GLP-1 manufacturers and compounding pharmacies are deteriorating as weight loss pills enter the U.S. market and competition intensifies. Hims & Hers is selling the ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a yearlong campaign to stop independent labs from producing cheaper versions. Former Novo Nordisk CEO ...

Eli Lilly has issued a new warning against buying compounded versions of its drug tirzepatide, claiming to have found potentially dangerous impurities. Reading time 3 minutes Trying to get a bargain ...

Novo Nordisk President and CEO Lars Fruergaard Jorgensen, left, is greeted by Senate Health, Education, Labor, and Pensions Committee Chairman Bernie Sanders (I-VT) before a hearing in the Dirksen ...